Form 4 Tracker
Immunome Inc.
IMNM

16 insider filings · Latest: Jun 25, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 19, 2024Sep 19 6:18 PMRosett Max
Proposed Sale
14,380$16.01$230.2K

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 25, 2026Jun 29 8:52 PMRobert LechleiderChief Medical Officer
Option Exercise
55,000$8.73345,000(D)

View →

Jun 15, 2026Jun 17 9:26 PMMax RosettChief Financial Officer
Option Exercise
60,000$1.050(D)

View →

Jun 10, 2026Jun 12 9:58 PMSandra M SwainDirector
Grant/Award
9,897$18.169,897(D)

View →

Jun 10, 2026Jun 12 9:56 PMWAGENHEIM PHILIPDirector
Grant/Award
9,897$18.169,897(D)

View →

Jun 10, 2026Jun 12 9:54 PMJean Jacques BienaimeDirector
Grant/Award
9,897$18.169,897(D)

View →

Jun 10, 2026Jun 12 9:51 PMJames P BoylanDirector
Grant/Award
9,897$18.169,897(D)

View →

Jun 10, 2026Jun 12 9:48 PMBarchas IsaacDirector
Grant/Award
9,897$18.169,897(D)

View →

Jun 10, 2026Jun 12 9:45 PMCarol SchaferDirector
Grant/Award
9,897$18.169,897(D)

View →

Apr 2, 2026Apr 3 11:46 PMMax RosettChief Financial Officer
Option Exercise
71,561$1.350(D)

View →